XML 34 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Restructuring, Impairment and Related Charges
3 Months Ended
Mar. 31, 2023
Restructuring and Related Activities [Abstract]  
Restructuring, Impairment and Related Charges
16.
Restructuring, Impairment and Related Charges

In January 2022, we committed to a restructuring initiative designed to drive operational changes in our business processes, efficiencies and cost savings to advance our corporate strategy and development programs. The restructuring initiative included, among other components, consolidation and rationalization of our facilities, reprioritization of development programs and the reduction in our workforce. We estimate to incur total charges in the range of approximately $6.0 million to $9.0 million for the fiscal year 2023, consisting primarily of winding down costs, exit and other related costs, impairments and write-offs of long-lived assets, and severance and employee-related costs. Our estimate of the range of costs is subject to certain assumptions and actual results may differ from those estimates or assumptions. We may also incur additional costs that are not currently foreseeable as we continue to evaluate our restructuring alternatives to drive operational changes in business processes, efficiencies and cost savings.

Restructuring, impairment and related charges included in our condensed statement of operations for the three months ended March 31, 2023 and March 31, 2022 consisted of the following:

 

 

 

Three Months Ended March 31,

 

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Long-lived assets impairments and write-offs

 

$

 

 

$

12,653

 

Severance and employee-related costs

 

 

143

 

 

 

7,016

 

Winding down, exit and other related costs

 

 

3,226

 

 

 

2,993

 

Total

 

$

3,369

 

 

$

22,662

 

The following table summarizes the activity related to the restructuring liabilities associated with our restructuring initiatives for the three months ended March 31, 2023:

 

 

 

Three Months Ended March 31,

 

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Beginning balance

 

$

6,826

 

 

$

 

Reclassification of final payment obligation related to a manufacturing
  agreement that was recognized in the prior period (see Note 13)

 

 

 

 

 

2,185

 

Restructuring, impairment and related charges

 

 

3,369

 

 

 

22,662

 

Cash payments

 

 

(8,905

)

 

 

(3,867

)

Noncash activities

 

 

 

 

 

(13,825

)

Ending balance

 

$

1,290

 

 

$

7,155

 

 

 

 

 

 

 

 

 

March 31, 2023

 

 

December 31, 2022

 

 

 

(in thousands)

 

Accounts payable

 

$

98

 

 

$

896

 

Accrued compensation and benefits

 

 

143

 

 

 

41

 

Accrued research and development liabilities

 

 

1,049

 

 

 

5,889

 

Total

 

$

1,290

 

 

$

6,826